Dolby Laboratories (NYSE:DLB) Receives $95.75 Average Price Target from Brokerages

Dolby Laboratories (NYSE:DLBGet Free Report) has been given an average rating of “Moderate Buy” by the five analysts that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $95.75.

DLB has been the subject of several recent research reports. Rosenblatt Securities restated a “buy” rating and set a $95.00 target price on shares of Dolby Laboratories in a research report on Friday, August 1st. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, August 30th. Barrington Research restated an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a research report on Friday. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Finally, Robert W. Baird started coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They issued a “neutral” rating and a $74.00 price target for the company.

Check Out Our Latest Stock Analysis on DLB

Insider Buying and Selling

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 39,875 shares of the company’s stock in a transaction that occurred on Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total value of $2,983,447.50. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at $8,583,724.50. This represents a 25.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the transaction, the senior vice president owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 99,366 shares of company stock valued at $7,352,963. Company insiders own 38.39% of the company’s stock.

Hedge Funds Weigh In On Dolby Laboratories

A number of hedge funds have recently modified their holdings of DLB. Securian Asset Management Inc. lifted its holdings in shares of Dolby Laboratories by 3.0% in the first quarter. Securian Asset Management Inc. now owns 4,648 shares of the electronics maker’s stock worth $373,000 after buying an additional 137 shares in the last quarter. Boothbay Fund Management LLC lifted its holdings in shares of Dolby Laboratories by 4.1% in the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after buying an additional 157 shares in the last quarter. MAI Capital Management lifted its holdings in shares of Dolby Laboratories by 87.1% in the first quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after buying an additional 162 shares in the last quarter. Equitable Trust Co. lifted its holdings in shares of Dolby Laboratories by 3.3% in the second quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker’s stock worth $413,000 after buying an additional 177 shares in the last quarter. Finally, Net Worth Advisory Group lifted its holdings in shares of Dolby Laboratories by 5.2% in the first quarter. Net Worth Advisory Group now owns 3,591 shares of the electronics maker’s stock worth $288,000 after buying an additional 178 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.

Dolby Laboratories Stock Down 0.9%

Shares of DLB stock opened at $71.48 on Friday. The company has a 50 day moving average price of $73.73 and a 200-day moving average price of $75.53. Dolby Laboratories has a 52 week low of $68.24 and a 52 week high of $89.66. The firm has a market capitalization of $6.85 billion, a PE ratio of 26.18 and a beta of 0.93.

Dolby Laboratories (NYSE:DLBGet Free Report) last announced its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, topping analysts’ consensus estimates of $0.72 by $0.06. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm had revenue of $315.55 million during the quarter, compared to analyst estimates of $305.23 million. During the same period in the previous year, the business posted $0.71 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories’s dividend payout ratio is presently 48.35%.

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Stories

Analyst Recommendations for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.